TheResearchPost is the open-access, peer-reviewed publishing channel on a visual platform that offers the innovative solution for rapid and engaging peer-reviewed publication. Data show that it typically takes 1 to 2 years or longer to write and publish in traditional peer-reviewed medical journals. That is way too long. TheResearchPost can cut that time to write and publish to just a couple months. In addition, your publication is fully open access and published in an engaging and easy to understand format to meet the needs of busy healthcare professionals. Think of TheResearchPost as a journal alternative with the key objectives to accelerate the pace of medical research communication and publish quality data in an engaging visual format that better matches how people read and share information today.

Yes. We work to complete peer-review with relevant experts in about 2 to 4 weeks.

Yes. TheResearchPost is fully open access. We advise authors to select an appropriate copyright for their published work that fits their needs, so they can use their published data as needed for other communication activities.

Yes. Our editorial advisory board includes experts across different therapeutic areas and patient communications. We are always looking to add other experts to our advisory board, so feel free to reach out if interested.

Yes. A DOI is important to ensure that peer-reviewed content published in TheResearchPost is readily referenceable and discoverable.

As a new concept in medical publishing, TheResearchPost does not have an impact factor yet. We recognize that the impact factor is a widely used metric for academic publications, but substantial debate continues about the limitations of such metrics. We accept that such metrics may have different importance and incentives for academic vs industry researchers and across different scientific disciplines.
TheResearchPost is a signatory to DORA, the Declaration of Research Assessment, for which the key principle is improving the ways academic institutions, funding agencies, and other groups evaluate the output of scientific research.

Yes. TheResearchPost is indexed by CrossRef. Application for other indexing and listing services is planned for the near future. Your submissions are important to help us achieve milestones necessary to apply for other indexing services.

Yes. Currently the processing charge is $2,500. We can reduce or waive the processing charge for certain authors, such as for student authors. There is no additional charge for rapid peer-review and publication.

TheResearchPost accepts quality research post submissions across all areas of medical, pharmaceutical, and healthcare research. We accept primary and secondary clinical and preclinical research across all therapeutic areas, as well as health economics and outcomes research (HEOR), real-world evidence (RWE), patient-reported outcomes (PROs), patient journey/experience research, registry data, health policy, brief reports, and other data types. If needed to determine interest, please contact us at editor@theresearchpost.com to query about your data..

Yes. TheResearchPost is well-suited to publish secondary data from clinical and real-world studies where the primary methods and results are already published in manuscript form. This can save time and cost to publish by allowing authors to develop their research post submissions from existing materials, eg, data slides or poster presentations from a medical congress, instead of writing secondary long-form text manuscripts that may be subject to the typical long development and publication timelines.

TheResearchPost is designed to publish high quality original data. We will consider data review submissions that address a specific medical topic. Please send a query to editor@theresearchpost.com to determine interest prior to developing your data review submission.

Yes. TheResearchPost, with its engaging visual format, is well-suited to accept plain language summaries (PLS) of original publications in TheResearchPost or other medical journals. A PLS would need to follow TheResearchPost submission guidelines and can be submitted through the Submit link on the homepage.

TheResearchPost can accept various file formats. For slide submissions, which are the primary format we have published so far, the slides must be converted to .pdf for submission, with about 10-15 slides to present the data. TheResearchPost can accept submissions in video and other formats. Visual abstracts, which are required, need to be submitted in .jpeg or .png image file formats. Text abstracts are also required and are typed into the submission form. Please contact us at editor@theresearchpost.com with questions about the submission process or other file formats.

The text abstract is required for indexing services so an abstract summary of your research is available during literature searches. An abstract word limit of 175-200 words is preferred.

A key objective of TheResearchPost is to accelerate the time to publish peer-reviewed research. With our accelerated publishing process, it is not necessary to publish preprints.

Yes. At least one author needs to be a member to submit, and we encourage all authors on a research post submission to become members. There is no fee to sign up to TheResearchPost.

Yes. TheResearchPost is a viable publishing partner for industry-supported and academic research. The pharmaceutical industry funds about half of all medical research, so TheResearchPost is certainly interested in publishing industry-supported research. We recognize that the pharmaceutical and medical device industries have different incentives to publish when compared with academic researchers, and we strive to work closely with authors from all organizational types to support their peer-reviewed publishing needs.

TheResearchPost is flipping the script on publication extenders. Publication extenders such as slides or videos, which are recent additions to the publishing landscape, are intended to make the content of a long-form text manuscript more accessible. Research consistently shows that readers prefer shorter and visual formats and that the rapidly expanding volume of published research leads to information overload. TheResearchPost's brief, visual format allows the primary peer-reviewed publication to be in a shorter, more engaging format, such as slides, graphics, or video. All of our submissions require a visual abstract to summarize the study or a key data finding.
We feel the growing interest in publication extenders stems from the mismatch between today’s communication preferences and the format of traditional long-form text manuscripts. However, if an author wishes to submit a more detailed text description of the study methodology, results, or discussion, TheResearchPost can support it as an extension of the primary research post submission through a separate link or as a blog post on the author’s page.

We recognize that you have many medical journal options to choose from - tens of thousands of them actually - to submit and publish your research. TheResearchPost offers a journal alternative with features you expect, like quality peer-review and open-access. Additional features of TheResearchPost include an innovative and engaging visual format that allows benefits like 1) faster writing, peer-review and publication times vs a long-form text manuscript for a journal or preprint, 2) better readability and engagement, and 3) unrestricted shareability.
We also recognize that the pace and competitiveness of research is increasing year after year. These research dynamics result in a shorter shelf life for research and potential missed opportunity costs resulting from the typical 1- to 2-year publishing timeline. TheResearchPost is designed to match today's communication environment, to shorten the timeline to publish, and to communicate the primary publication in an engaging visual format that better matches how people read and share information today.
Finally, we believe TheResearchPost offers a cost-effective solution to publish your results, with authors in many cases being able to work from existing data slides to submit their research post without the time and cost of writing a long-form text manuscript. This approach can be effective for publishing secondary data research posts where the primary methods and results are already published in a long-form text manuscript.

That's a great question...what about copyrights? TheResearchPost is fully open access and wants the authors to keep the copyright to their published data. It is your research, and you've spent substantial time and money for the study, so you should own your published data. TheResearchPost recommends that authors select a copyright for their published research post that allows them and their institutions to use the data as needed. We only ask for attribution to the original published version in TheResearchPost. We will not charge large sums for you to buy back rights to use your published data.

As the saying goes, TheResearchPost is not your father's (or grandfather's) medical journal. TheResearchPost is a peer-reviewed, open-access, publishing channel with an engaging visual format that is designed to address some of the widely acknowledged limitations of traditional long-form text academic articles. Research shows that many published papers are not read at length and that readers typically scan or skim parts of published papers. TheResearchPost provides an engaging solution to rapidly communicate your research effectively in today's world of information overload and competing time demands.